K
Edit properties
Sector
Biotech
Status
active
Stage
Series B
HQ City
—
Subsector
Oral medicines for immunological and chronic diseases
Founded
—
AKA
—
Website
Notes
—
+ Add financial data — ARR, revenue, headcount, EBITDA
Latest news
From Google NewsNo news yet. Click Refresh to pull from Google News.
Funding Rounds
| Round | Amount | Post-Money Val. | Date | Lead | All Investors | |
|---|---|---|---|---|---|---|
| Series B | $50M | — | 2026-08-13 | Forge Life Science Partners | Forge Life Science Partners, Longwood Fund, Alexandria Venture Investments, Foresite Capital, Lilly Asia Ventures, Nextech Invest | ↗ comps |